[HTML][HTML] Cervical cancer in low and middle‑income countries
Cervical cancer is a malignant tumour that occurs in the cervix and is classified into two
histological types, adenocarcinoma and squamous cell carcinoma (SCC); SCC is more …
histological types, adenocarcinoma and squamous cell carcinoma (SCC); SCC is more …
Human papillomavirus vaccines: an updated review
L Cheng, Y Wang, J Du - Vaccines, 2020 - mdpi.com
Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past
decade, have shown promising results in decreasing HPV infection and related diseases …
decade, have shown promising results in decreasing HPV infection and related diseases …
NCCN Guidelines® insights: Head and neck cancers, version 1.2022: Featured updates to the NCCN guidelines
JJ Caudell, ML Gillison, E Maghami, S Spencer… - Journal of the National …, 2022 - jnccn.org
The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity
(including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer …
(including mucosal lip), pharynx, larynx, and paranasal sinuses. Occult primary cancer …
[HTML][HTML] HPV vaccination and the risk of invasive cervical cancer
Background The efficacy and effectiveness of the quadrivalent human papillomavirus (HPV)
vaccine in preventing high-grade cervical lesions have been shown. However, data to …
vaccine in preventing high-grade cervical lesions have been shown. However, data to …
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries
Background WHO is developing a global strategy towards eliminating cervical cancer as a
public health problem, which proposes an elimination threshold of four cases per 100 000 …
public health problem, which proposes an elimination threshold of four cases per 100 000 …
Cervical cancer: a global health crisis
W Small Jr, MA Bacon, A Bajaj, LT Chuang, BJ Fisher… - Cancer, 2017 - Wiley Online Library
Cervical cancer is the fourth most common malignancy diagnosed in women worldwide.
Nearly all cases of cervical cancer result from infection with the human papillomavirus, and …
Nearly all cases of cervical cancer result from infection with the human papillomavirus, and …
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Cervical cancer is the second most commonly diagnosed cancer and the third leading cause
of cancer death among females in less developed countries. There were an estimated 527 …
of cancer death among females in less developed countries. There were an estimated 527 …
The natural history of human papillomavirus infection
S de Sanjose, M Brotons, MA Pavon - Best practice & research Clinical …, 2018 - Elsevier
Human papillomavirus (HPV) is a small double-stranded DNA virus that commonly infects
humans. The oncogenic characteristics of HPV derive from the oncoproteins E6 and E7 that …
humans. The oncogenic characteristics of HPV derive from the oncoproteins E6 and E7 that …
Trends in human papillomavirus–associated cancers, demographic characteristics, and vaccinations in the US, 2001-2017
CI Liao, AA Francoeur, DS Kapp, MAP Caesar… - JAMA network …, 2022 - jamanetwork.com
Importance Nearly 45 000 human papillomavirus (HPV)-associated cancers are diagnosed
annually in the US. The HPV vaccine has been approved since 2006, but information on the …
annually in the US. The HPV vaccine has been approved since 2006, but information on the …
[HTML][HTML] Cancer immunotherapy: opportunities and challenges in the rapidly evolving clinical landscape
Cancer immunotherapy is now established as a powerful way to treat cancer. The recent
clinical success of immune checkpoint blockade (antagonists of CTLA-4, PD-1 and PD-L1) …
clinical success of immune checkpoint blockade (antagonists of CTLA-4, PD-1 and PD-L1) …